article thumbnail

Research digest: The need for a Pharmacist Clinician Model in a collaborative workforce

Hospital Pharmacy Europe

A Pharmacists Clinician Model integrates pharmacists into a multidisciplinary care framework within the NHS, giving pharmacists increased responsibilities and incorporating pharmaceutical care needs with wider clinical assessment, diagnostic and clinical management responsibilities. Reference Rushworth, G et al.

article thumbnail

What HCPs think about COVID-19’s impact on cancer

pharmaphorum

Patients with diagnosed COVID-19 on active anti-cancer treatment, follow standard clinical management plans for delay or modification of cancer treatment in a patient with active infection’ [link]. Across both open and closed online networks HCPs are concerned about the future of patient care.

Hospitals 124
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Five for Friday January 13: Celebrating Success in Advancing Medication Use Quality

PQA

-- Amanda Ryan, PharmD, BCGP, CPHQ, PQA Director of Education Developing Data Standards to Elevate Pharmacists' Roles NCPDP's Lee Ann Stember outlined the support for the connectivity of health care data and the expanding role of pharmacists as they increasingly move deeper into providing patient care services in the community and the home.

article thumbnail

The evolution of the pharmacist prescriber: a prescription for change

Hospital Pharmacy Europe

As hospital pharmacists continue to expand their roles, the ability to prescribe medications either independently or in collaboration with medical prescribers presents an opportunity to alleviate the growing pressure on healthcare systems while enhancing patient care.

article thumbnail

Leading speciality pharmacies in pharma

Pharmaceutical Technology

Speciality pharmacies play a crucial role in medication dosing, disease and side effects management, and patient care. The expert services rendered by them help in improving patient outcomes, minimising costs of the healthcare system, improving medicinal adherence and persistency and saving clinicians’ time.

article thumbnail

The evolution of durvalumab in NSCLC care

Hospital Pharmacy Europe

That’s been driven by advancements in targeted therapies, immunotherapy and the more personalised approach to patient care,’ he says. And guidelines and protocols will need to be updated to reflect these evolutions of approaches to patient care. I’m optimistic we’ll see that.’

article thumbnail

Treatment innovations in cardiology: highlights from ESC Congress 2024

Hospital Pharmacy Europe

The ESC Congress 2024 spotlight was ‘Personalising Cardiovascular Care’, with the main aim of promoting tailored patient care and moving away from the one-size-fits-all approach to treatment. In light of HELIOS-B trial results , as Professor Esther Gonzalez Lopez commented, for patients with amyloidosis the future is brighter.